Chieh‐Hsiang Lu

4.1k total citations
29 papers, 545 citations indexed

About

Chieh‐Hsiang Lu is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Chieh‐Hsiang Lu has authored 29 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Chieh‐Hsiang Lu's work include Diabetes Management and Research (4 papers), Diabetes Treatment and Management (4 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). Chieh‐Hsiang Lu is often cited by papers focused on Diabetes Management and Research (4 papers), Diabetes Treatment and Management (4 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). Chieh‐Hsiang Lu collaborates with scholars based in Taiwan, South Korea and Australia. Chieh‐Hsiang Lu's co-authors include Ying‐Ray Lee, Shu‐Hsin Chen, Yun-Ping Lim, Yi‐Wen Liu, Lee‐Ming Chuang, Shih‐Che Hua, Yi‐Ping Chang, Hsiu‐Chuan Chou, Hong‐Lin Chan and Satoshi Kokubo and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Archives of Biochemistry and Biophysics.

In The Last Decade

Chieh‐Hsiang Lu

29 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chieh‐Hsiang Lu Taiwan 15 227 133 72 65 63 29 545
Yao Xiao China 13 257 1.1× 82 0.6× 48 0.7× 43 0.7× 53 0.8× 38 654
Naureen Fatima India 10 197 0.9× 73 0.5× 59 0.8× 34 0.5× 51 0.8× 15 616
Mohammad Shoeb United States 10 293 1.3× 58 0.4× 47 0.7× 46 0.7× 21 0.3× 12 615
Jing He China 13 159 0.7× 80 0.6× 32 0.4× 51 0.8× 57 0.9× 47 568
Sheng‐Chun Chiu Taiwan 16 288 1.3× 106 0.8× 80 1.1× 32 0.5× 62 1.0× 23 662
Bilgen Ekim Üstünel Germany 7 227 1.0× 123 0.9× 133 1.8× 75 1.2× 19 0.3× 10 547
Nada A. Ashour Egypt 5 129 0.6× 101 0.8× 50 0.7× 56 0.9× 18 0.3× 8 467
Dong-Jik Shin South Korea 15 244 1.1× 112 0.8× 129 1.8× 129 2.0× 60 1.0× 21 794
Fabrícia Dietrich Brazil 13 116 0.5× 43 0.3× 26 0.4× 190 2.9× 58 0.9× 22 486
Paola Romecín Spain 11 128 0.6× 57 0.4× 26 0.4× 42 0.6× 45 0.7× 22 483

Countries citing papers authored by Chieh‐Hsiang Lu

Since Specialization
Citations

This map shows the geographic impact of Chieh‐Hsiang Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chieh‐Hsiang Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chieh‐Hsiang Lu more than expected).

Fields of papers citing papers by Chieh‐Hsiang Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chieh‐Hsiang Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chieh‐Hsiang Lu. The network helps show where Chieh‐Hsiang Lu may publish in the future.

Co-authorship network of co-authors of Chieh‐Hsiang Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Chieh‐Hsiang Lu. A scholar is included among the top collaborators of Chieh‐Hsiang Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chieh‐Hsiang Lu. Chieh‐Hsiang Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Kuan‐Hung, Wayne Huey‐Herng Sheu, Yen‐Po Yeh, et al.. (2024). Determinants of early chronic kidney disease in patients with recently diagnosed type 2 diabetes mellitus: a retrospective study from the Taiwan Diabetes Registry. BMC Nephrology. 25(1). 133–133. 1 indexed citations
2.
Lu, Jin‐Ying, Horng‐Yih Ou, Chung‐Ze Wu, et al.. (2023). A randomized trial on the effect of transcutaneous electrical nerve stimulator on glycemic control in patients with type 2 diabetes. Scientific Reports. 13(1). 2662–2662. 2 indexed citations
3.
4.
5.
Chang, Yi‐Cheng, Ching‐Chu Chen, Kong‐Han Ser, et al.. (2020). The Effects of Bariatric Surgery on Renal, Neurological, and Ophthalmic Complications in Patients with Type 2 Diabetes: the Taiwan Diabesity Study. Obesity Surgery. 31(1). 117–126. 15 indexed citations
6.
Tsai, Ching-Fang, et al.. (2020). Diabetes pay-for-performance program can reduce all-cause mortality in patients with newly diagnosed type 2 diabetes mellitus. Medicine. 99(7). e19139–e19139. 12 indexed citations
7.
Tai, Tsai-Sung, Ni Tien, Charles C. N. Wang, et al.. (2019). Sesamin, a Naturally Occurring Lignan, Inhibits Ligand-Induced Lipogenesis through Interaction with Liver X Receptor Alpha (LXRα) and Pregnane X Receptor (PXR). Evidence-based Complementary and Alternative Medicine. 2019. 1–17. 26 indexed citations
8.
Chen, Shu‐Hsin, et al.. (2019). Autophagy Modulation in Human Thyroid Cancer Cells following Aloperine Treatment. International Journal of Molecular Sciences. 20(21). 5315–5315. 25 indexed citations
9.
Chou, Hsiu‐Chuan, Chieh‐Hsiang Lu, Yi-Ting Tsai, et al.. (2018). Proteomic analysis of evodiamine-induced cytotoxicity in thyroid cancer cells. Journal of Pharmaceutical and Biomedical Analysis. 160. 344–350. 15 indexed citations
10.
Lu, Chieh‐Hsiang, Shu‐Hsin Chen, Yi‐Wen Liu, et al.. (2016). Honokiol, a potential therapeutic agent, induces cell cycle arrest and program cell death in vitro and in vivo in human thyroid cancer cells. Pharmacological Research. 115. 288–298. 54 indexed citations
11.
Lin, Shi-Dou, Shih‐Tzer Tsai, Shih‐Te Tu, et al.. (2014). Glycosylated hemoglobin level and number of oral antidiabetic drugs predict whether or not glycemic target is achieved in insulin-requiring type 2 diabetes. Primary care diabetes. 9(2). 135–141. 12 indexed citations
12.
Lu, Chieh‐Hsiang, Ta-Jen Wu, Kuang‐Chung Shih, et al.. (2012). Safety and efficacy of twice-daily exenatide in Taiwanese patients with inadequately controlled type 2 diabetes mellitus. Journal of the Formosan Medical Association. 112(3). 144–150. 12 indexed citations
13.
Lu, Chieh‐Hsiang, et al.. (2012). Sacroiliitis-like pain as the initial presentation of primary hyperparathyroidism. Archives of Osteoporosis. 7(1-2). 315–318. 3 indexed citations
14.
Chen, Chia-Ching, Yiwen Chen, Wen-Li Lee, et al.. (2012). Hemopexin is up-regulated in plasma from type 1 diabetes mellitus patients: Role of glucose-induced ROS. Journal of Proteomics. 75(12). 3760–3777. 25 indexed citations
15.
Lu, Chieh‐Hsiang, Szu‐Ting Lin, Hsiu‐Chuan Chou, Ying‐Ray Lee, & Hong‐Lin Chan. (2012). Proteomic analysis of retinopathy-related plasma biomarkers in diabetic patients. Archives of Biochemistry and Biophysics. 529(2). 146–156. 32 indexed citations
16.
Lu, Chieh‐Hsiang, et al.. (2012). Autophagy induction of reversine on human follicular thyroid cancer cells. Biomedicine & Pharmacotherapy. 66(8). 642–647. 34 indexed citations
17.
Hua, Shih‐Che, Tien‐Chun Chang, Hau‐Ren Chen, et al.. (2012). Reversine, a 2,6-disubstituted Purine, as an Anti-cancer Agent in Differentiated and Undifferentiated Thyroid Cancer Cells. Pharmaceutical Research. 29(7). 1990–2005. 40 indexed citations
18.
Lu, Chieh‐Hsiang & Yuan‐Horng Yan. (2009). Risperidone-associated newly diagnosed diabetes and fatal diabetes ketoacidosis in a young schizophrenic patient. Diabetes Research and Clinical Practice. 83(2). e66–e67. 5 indexed citations
19.
Lu, Chieh‐Hsiang, et al.. (2008). Pancreatic Insulinoma Presenting with Episodes of Hypoinsulinemic Hypoglycemia in Elderly ---- A Case Report. 19(5). 432–436. 1 indexed citations
20.
Sung, Sheng‐Feng & Chieh‐Hsiang Lu. (2007). Focal Neurological Symptoms as the Presenting Manifestations of Nonketotic Hyperglycemia: Report of Two Cases. 18(4). 206–211. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yao Xiao Breakdown of academic impact, for papers by Naureen Fatima Breakdown of academic impact, for papers by Mohammad Shoeb Breakdown of academic impact, for papers by Jing He Breakdown of academic impact, for papers by Sheng‐Chun Chiu Breakdown of academic impact, for papers by Bilgen Ekim Üstünel Breakdown of academic impact, for papers by Nada A. Ashour Breakdown of academic impact, for papers by Dong-Jik Shin Breakdown of academic impact, for papers by Fabrícia Dietrich Breakdown of academic impact, for papers by Paola Romecín
Rankless by CCL
2026